DWTX

Dogwood Therapeutics, Inc. - Common Stock (DWTX)

About Dogwood Therapeutics, Inc. - Common Stock (DWTX)

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Details

Daily high

$1.64

Daily low

$1.46

Price at open

52 Week High

$7.20

52 Week Low

$1.28

Market cap

51.7M

Dividend yield

Volume

1,962

Avg. volume

64,598

P/E ratio

-.17

Dogwood Therapeutics, Inc. - Common Stock News